CellBioN, Quracle Spark Commercialization Hopes[K-bio Pulse] 김지완 2026.01.30 오전 08:10 Cellbion Reports Positive Phase 2 Results in Prostate Cancer Therapy 유진희 2025.09.04 오후 06:00 Curacle jumps on Boryung tie-up; NextBiomedical climbs[K-bio Pulse] 석지헌 2025.09.12 오전 07:54 From Corestem to Yuhan: Cellbion Eyes Fast-Track Path for Lu-177-DGUL 유진희 2025.08.27 오전 08:27 Cellbion's Radiopharmaceutical Gains Global Pharma Attention, Expanding Collaborations Expec... 유진희 2025.03.04 오후 01:44 Limit-Up L&C Bio: “No CAPA Issues”; Lituo Shortage Easing Soon[K-Bio Pulse] 나은경 2025.09.08 오전 09:30 Cellbion CEO “We’ll Prove Orphan Drug Success...Next Month Is the Turning Point” 유진희 2025.11.17 오전 10:30 CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse] 김진수 2025.03.27 오전 08:29 Cellbion’s radiotherapy shows 35% ORR, looks to expand Merck ties 유진희 2025.09.05 오전 08:30 HK inno.N Rises on Strong Earnings; Eyes on Cellbion Ahead of Clinical Readout[K-Bio Pulse] 임정요 2025.08.01 오전 08:30 더 보기 로딩중..
Cellbion
Cellbion
![CellBioN, Quracle Spark Commercialization Hopes[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2026/01/PS26013000282b.jpg)
![Curacle jumps on Boryung tie-up; NextBiomedical climbs[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/09/PS25091200180b.jpg)
![Limit-Up L&C Bio: “No CAPA Issues”; Lituo Shortage Easing Soon[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/09/PS25090800358b.jpg)
![CellBion Jumps Over 10% on Expanded Combo Trial With Keytruda [K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032700436b.jpg)
![HK inno.N Rises on Strong Earnings; Eyes on Cellbion Ahead of Clinical Readout[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/08/PS25080100497b.jpg)